T1	Participants 272 322	may be beneficial in patients with type 2 diabetes
T2	Participants 454 494	type 2 diabetic patients remains unknown
T3	Participants 617 652	eight patients with type 2 diabetes
T4	Participants 959 1049	Participants, caregivers and those assessing the outcomes were blinded to group assignment
T5	Participants 1983 2009	n type 2 diabetic patients
T6	Participants 2435 2515	may be beneficial for prevention of atherosclerosis in type 2 diabetic patients.
